# GHK-Cu Research: Collagen, Genes, Hair and Wound-Healing Evidence > The GHK-Cu research record, dated and sourced: collagen dose-response, ~31% gene modulation, the ALAVAX hair-count RCT, wound-healing and neuroprotection findings, each cited. Collagen synthesis, gene modulation, hair growth, wound healing and neuroprotection — each finding dated, classed by evidence grade, and reconciled to its primary source. ## Collagen synthesis: the foundational dose-response The oldest hard number in the GHK-Cu record is a dose-response curve. In human fibroblast cultures, the tripeptide-copper complex stimulated collagen synthesis beginning between 10^-12 and 10^-11 M, maximized near 10^-9 M, and did so without any change in cell number — meaning the effect was metabolic, not a consequence of more cells [1]. This 1988 finding from Maquart and colleagues established that GHK liberated from collagen could drive local repair, and it remains the anchor for every skin and wound claim that follows. The matrix effect is not collagen alone. Reviews of the clinical and in-vitro literature document GHK-Cu stimulating synthesis of collagen, dermatan sulfate, chondroitin sulfate and the proteoglycan decorin, alongside placebo-controlled improvements in skin laxity, clarity, fine lines and wrinkle depth [3]. The copper ion contributes directly here: it is the cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin into mature, load-bearing fiber [6]. ## Copper peptide benefits reported in research Copper peptide benefits in the GHK-Cu literature cluster into a small set of well-documented effects, each tied to a mechanism. The first is matrix synthesis: dose-dependent collagen production in fibroblasts [1] plus dermatan sulfate, chondroitin sulfate and decorin [3]. The second is matrix remodeling — modulation of MMP-2 and MMP-9 against their TIMP inhibitors, shifting tissue toward controlled repair rather than degradation [6]. The third is angiogenesis and tissue support. A foundational tissue-remodeling review reports GHK increasing VEGF, FGF-2, NGF, neurotrophins 3 and 4 and erythropoietin, while suppressing free radicals, thromboxane, TGF-beta-1, TNF-alpha and protein glycation and chemoattracting repair cells [6]. The fourth is the genome-level signature: a Connectivity Map analysis reports GHK altering about 31.2% of human genes at a 50%-or-greater threshold, with strong upregulation of the ubiquitin-proteasome system (41 genes up, 1 down) and of DNA-repair and antioxidant gene sets [2]. These are research findings in cell and review literature, not human outcome claims, and the [copper peptide side effects](/faq) and limits are posted separately on the FAQ. ## Copper peptide vs retinol in the research record ### Copper peptide vs retinol in the research record The most-cited head-to-head figure comes from a single comparative dataset: topical GHK-Cu increased procollagen synthesis in 70% of treated subjects, versus 50% for vitamin C and 40% for retinoic acid [3]. A 2025 review repeats the same 70%-versus-40% comparison against retinoic acid while framing GHK's poor stratum-corneum permeability as the central formulation challenge [11]. This is one comparison, not a body of head-to-head trials, and it is presented as a research finding rather than a recommendation to choose one ingredient over another. ### Is GHK-Cu better than retinol? One review reported topical GHK-Cu increased procollagen synthesis in 70% of subjects versus 40% for retinoic acid [3]. That is a single comparative dataset, not a controlled head-to-head trial, so it is reported here as a research finding and not a ranking. The two ingredients act by different mechanisms — GHK-Cu through copper-dependent matrix synthesis, retinoids through nuclear-receptor signaling. ### Is GHK-Cu peptide really anti-aging? Gene-expression analyses report GHK alters about 31.2% of human genes at a 50%-or-greater change threshold toward repair and antioxidant programs [2], and plasma GHK declines from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60 [3]. Most of the supporting evidence is in vitro or rodent, so these are described as research findings rather than proven anti-aging outcomes in humans. ### Does GHK-Cu actually increase collagen production? In human fibroblast cultures GHK-Cu increased collagen synthesis dose-dependently — onset 10^-12 to 10^-11 M, peak near 10^-9 M — without changing cell number [1]. A GHK-Cu plus low-molecular-weight hyaluronic-acid combination raised collagen IV synthesis up to 25.4-fold in fibroblast culture and 2.03-fold in ex-vivo skin [8]. The collagen effect is among the best-replicated findings in the record. ## Copper peptide hair growth in study models ### Copper peptide hair growth in study models The strongest controlled human signal for copper-peptide hair growth is the ALAVAX trial: over six months, 45 men with androgenetic alopecia using a 5-aminolevulinic-acid plus GHK complex gained 52.6 hairs at 100 mg/mL and 71.5 at 50 mg/mL, versus 9.6 for placebo (p<0.05), with no adverse events [4]. Preclinically, a 2% GHK-Cu ionic-liquid microemulsion drove mouse hair follicles into anagen within 6 days and raised hair density at 28 days [12]. ### Do copper peptides stimulate hair growth? A 6-month randomized trial of 45 men using a 5-ALA plus GHK complex showed significant hair-count gains versus placebo [4], and a 2% GHK-Cu microemulsion drove follicles into the anagen phase in mice [12]. These are study findings in specific formulations, not a general regrowth claim for pure GHK-Cu. ### Does copper peptide regrow hair? The strongest controlled signal is the ALAVAX (5-ALA plus GHK) hair-count trial [4]; preclinical work shows angiogenic, anagen-promoting effects [12]. The evidence is limited and formulation-specific, so the record supports a measured signal in studied formulations, not a blanket regrowth claim. ### Does copper peptide work for hair growth? Research reports VEGF and Wnt/beta-catenin activation, microvascular angiogenesis and anagen induction in animal and ex-vivo models [12], plus the human ALAVAX trial [4]. Effects are described within the studied formulations and doses, not generalized beyond them. ### How long does GHK-Cu take to regrow hair? The human hair-count trial ran over 6 months [4]; an ionic-liquid-microemulsion mouse study saw follicles enter anagen within 6 days and higher density by 28 days [12]. These timelines come from study designs, not a usage protocol. ### Is copper a DHT blocker? The copper-peptide hair mechanism in research is non-androgenic. The 2% GHK-Cu microemulsion study reported anagen induction with no change in testosterone or estradiol [12], distinct from DHT-pathway agents. The pathways activated were Wnt/beta-catenin and VEGF/HGF, not androgen suppression. ## Wound healing, inflammation and gene effects ### Can GHK-Cu help with wound healing? GHK-Cu stimulates wound healing across numerous models, raising collagen, elastin, VEGF and FGF-2 while suppressing free radicals and TGF-beta-1 [6]. As a delivery example, a biotinylated-GHK collagen matrix accelerated dermal wound closure in rats [13]. This is preclinical and review evidence; topical wound trials in humans remain limited. ### Does GHK-Cu affect inflammation? Tissue-remodeling reviews describe GHK-Cu suppressing free radicals, TGF-beta-1, TNF-alpha and protein glycation while chemoattracting repair cells such as macrophages and mast cells [6]. At the genome level it suppresses NF-kB-driven inflammatory gene expression [2]. Anti-inflammatory effects are documented across wound and organ-injury models, largely preclinical. ### What genes does GHK-Cu affect? Connectivity Map analyses report GHK shifts about 31.2% of human genes at a 50%-or-greater threshold, upregulating wound-repair, DNA-repair, antioxidant and ubiquitin-proteasome genes (41 up, 1 down) and suppressing NF-kB inflammation [2]. The often-quoted '~4,000 genes' figure is an extrapolation; the verified threshold table reports on the order of 2,100 genes. ### What is the neuroprotective research on GHK-Cu? In-vitro work shows GHK sequesters copper to prevent metal-induced oxidative damage, and a biotinylated GHK-copper complex showed antioxidant and antiglycant activity against amyloid-beta/acrolein adducts relevant to neurodegeneration at 0-30 uM [9]. In rodents, GHK and its analogs produced anxiolytic effects [14] and reduced pain-induced aggressive-defensive behavior [15]. All of this is in-vitro or rodent evidence. ### Can GHK-Cu cross the blood-brain barrier? No validated human blood-brain-barrier penetration data exist. Rodent CNS effects in the literature were produced by routes such as intraperitoneal and intranasal administration [14], and free GHK is rapidly cleared from plasma to the dipeptide HK [10]. There is no human pharmacokinetic basis for CNS dosing. --- A compliance-grade ledger of the GHK-Cu copper-tripeptide literature — every collagen study, skin trial and regulatory status posted as a line item and reconciled to its source, with no clinic behind the statement and nothing here for sale.